Shares of athenahealth, Inc (NASDAQ:ATHN) have been given an average rating of “Hold” by the twenty-seven research firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, sixteen have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $142.85.
ATHN has been the topic of a number of analyst reports. KeyCorp reaffirmed a “buy” rating and set a $152.00 target price on shares of athenahealth in a research report on Friday, January 12th. Wells Fargo & Co dropped their target price on athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a research report on Monday, October 23rd. ValuEngine lowered athenahealth from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Oppenheimer reissued a “buy” rating and issued a $184.00 price objective on shares of athenahealth in a report on Friday, October 20th. Finally, BidaskClub lowered athenahealth from a “hold” rating to a “sell” rating in a report on Tuesday, January 16th.
Shares of athenahealth (ATHN) traded up $3.80 during midday trading on Friday, hitting $131.07. The stock had a trading volume of 571,880 shares, compared to its average volume of 564,213. athenahealth has a twelve month low of $95.01 and a twelve month high of $158.66. The stock has a market capitalization of $5,250.00, a price-to-earnings ratio of 100.82, a price-to-earnings-growth ratio of 2.41 and a beta of 1.35. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84.
In other athenahealth news, CEO Jonathan Bush sold 5,000 shares of athenahealth stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $122.69, for a total value of $613,450.00. Following the completion of the transaction, the chief executive officer now directly owns 320,807 shares in the company, valued at $39,359,810.83. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amy Abernethy sold 500 shares of athenahealth stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $134.18, for a total value of $67,090.00. Following the completion of the transaction, the director now owns 4,045 shares of the company’s stock, valued at $542,758.10. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 98,703 shares of company stock valued at $13,487,150. 3.20% of the stock is currently owned by insiders.
A number of hedge funds have recently modified their holdings of ATHN. Jackson Square Partners LLC boosted its stake in athenahealth by 55.4% in the third quarter. Jackson Square Partners LLC now owns 525,738 shares of the health services provider’s stock valued at $65,380,000 after acquiring an additional 187,491 shares during the period. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of athenahealth by 124.4% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 276,700 shares of the health services provider’s stock worth $34,410,000 after buying an additional 153,400 shares during the period. Sumitomo Mitsui Asset Management Company LTD boosted its position in shares of athenahealth by 40.3% during the fourth quarter. Sumitomo Mitsui Asset Management Company LTD now owns 454,160 shares of the health services provider’s stock worth $60,421,000 after buying an additional 130,545 shares during the period. Toronto Dominion Bank acquired a new position in shares of athenahealth during the second quarter worth approximately $16,863,000. Finally, First Trust Advisors LP boosted its position in shares of athenahealth by 7,309.7% during the third quarter. First Trust Advisors LP now owns 115,592 shares of the health services provider’s stock worth $14,375,000 after buying an additional 114,032 shares during the period.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.